Form 4: Pliant Therapeutics Chief Medical Officer Acquires Shares Following Performance Milestone

Eric Lefebvre, Chief Medical Officer of Pliant Therapeutics, acquired 24,063 shares of common stock on July 9, 2024, following the achievement of performance criteria related to the company's total shareholder return.

Summary

• Eric Lefebvre, the Chief Medical Officer of Pliant Therapeutics, acquired 24,063 shares of common stock on July 9, 2024.
• This acquisition was triggered by the vesting of performance-vested stock units granted on July 28, 2022.
• The vesting was contingent upon the achievement of pre-established performance criteria related to the company's total shareholder return relative to the Nasdaq Biotechnology Index.
• The Compensation Committee of the Issuer's Board of Directors certified the achievement of these performance criteria.
• Lefebvre also acquired 1,488 shares through an Employee Stock Purchase Plan.
• Following the transaction, Lefebvre beneficially owns 225,371 shares of Pliant Therapeutics common stock.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive as the vesting of performance-based stock units indicates the company has met certain performance targets. The insider's increased stake in the company can be seen as a positive signal.

Positives

• The vesting of performance-based stock units suggests that Pliant Therapeutics has met certain performance targets related to shareholder return.
• The acquisition of shares through the Employee Stock Purchase Plan indicates confidence in the company's future prospects by the Chief Medical Officer.

Future Outlook

The document does not contain specific forward-looking statements, but the vesting of performance-based stock units suggests an expectation of continued positive performance.

Industry Context

Form 4 filings are standard disclosures for company insiders and provide transparency into their transactions in the company's stock. The vesting of performance-based stock units is a common practice to align management's interests with those of shareholders.

Stakeholder Impact

• The acquisition of shares by a key executive could positively influence shareholder confidence.
• The achievement of performance criteria may positively impact employee morale.

Key Dates